Medicine shortages continue in Leda during the summer

Serious shortage of supplyOzempic Recently, a much bigger problem has been highlighted:Nearly a thousand drug orders missingAccording to the Spanish Agency for Medicines and Health Products (AEMPS). Although the focus was initially on this particular brand, the problem has worsened, affecting the Spanish population, especially patients with chronic diseases. According to the platform of patient organizations, they represent more than 54% of citizens over the age of 15.

But what are the hardest drugs to find in Lida Pharmacies At the beginning of this summer, what could make this situation worse?

And Study conducted by LUDA PartnersThe world’s only digital pharmacy network that allows immediate location of medicines in pharmacies, has revealed that people with diabetes continue to be the most affected by medicine shortages. In recent weeks, 33% of medicines available using this technology belong to a groupAntidiabetic. Specifically, the drug Trulicity, which is used to lower blood sugar levels from the age of 10 in people with type 2 diabetes, faces the biggest problems today.

secondly, Vaccines They represent 9% of the total. The shortage of Rotatec, an oral solution to prevent hospitalization for the treatment of gastroenteritis in newborns due to rotavirus, has been particularly noticeable in recent weeks. However, according to the Spanish Agency for Medicines and Health Products (AEMPS), the situation is starting to return to normal.

On the other hand, it came in third place. ADHD Treatmentswhich makes up 12% of the sites, with Concerta standing out.

Last month, LUDA identified 2,299 different health presentations and products, demonstrating the wide range of products that are in short supply in our country. Among the most affected drugs in Lida, in addition to those mentioned above, are Ozempic, Peloquin, Fosethalmic, and Urbinin, Each of them is used to treat different diseases.

This problem is not unique to Spain; other countries around us also face difficulties due to structural reasons that are difficult to solve, the most important of which is the relocation of production. The protests in countries like France are a clear example. However, the situation in Spain is getting worse due to the low cost of medicines, among other factors, a recurring theme in the pharmaceutical sector.